Integrating newfound evidence from preeclampsia-focused studies with those of other disease models reveals a complex interplay between HDACs and relevant signaling pathways [51,61,100,167,311,313], which may control the activity of HDAC9 and its regulation of downstream targets. Here, HDAC9 is linked to preeclampsia.